Vir Biotechnology Inc Capital Reinvestment Ratio

Latest as of June 2026: 0.00x

Vir Biotechnology Inc capital reinvestment ratio. Vir Biotechnology Inc (VIR) has a Capital Reinvestment Ratio of 0.00x as of June 2026, meaning it reinvests 0% of its operating cash flow ($123.33 Million) in capital expenditures ($32.00K). Check Vir Biotechnology Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$123.33 Million
USD

Capital Expenditures

$32.00K
USD

Data as of

Jun 2026
Most recent filing

Capital Reinvestment Ratio of Vir Biotechnology Inc (2022–2022)

Capital reinvestment ratio of Vir Biotechnology Inc from 2022 to 2022. This chart tracks Vir Biotechnology Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore VIR net asset momentum to track the company's year-over-year net asset growth rate.

Vir Biotechnology Inc Capital Reinvestment Ratio by Year (2022–2022)

Vir Biotechnology Inc capital reinvestment ratio by year from 2022 to 2022. For the full cash flow conversion analysis, see cash efficiency ratio of Vir Biotechnology Inc.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2022 0.04x $1.66 Billion $68.01 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow